- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10: 3 residues within 4Å:- Chain A: Q.15, N.48, P.606
Ligand excluded by PLIPNAG.11: 7 residues within 4Å:- Chain A: N.108, S.109, T.110, H.111, V.113, H.136, V.153
Ligand excluded by PLIPNAG.12: 5 residues within 4Å:- Chain A: N.307, P.554, K.555, T.556, L.557
Ligand excluded by PLIPNAG.13: 4 residues within 4Å:- Chain A: N.591, C.592, Q.619
- Chain C: Q.807
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain A: H.630, V.631, N.632
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain A: N.680, N.681, I.1101, G.1102
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain A: A.677, T.682, N.1045
Ligand excluded by PLIPNAG.17: 6 residues within 4Å:- Chain A: R.1044, N.1069, G.1070, T.1071, S.1072, F.1074
Ligand excluded by PLIPNAG.18: 5 residues within 4Å:- Chain A: R.146, N.147
- Chain B: Y.327, A.328, I.444
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain A: D.256, E.257, N.258
- Chain B: R.533
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain A: N.319, S.347, T.348, L.417
Ligand excluded by PLIPNAG.21: 6 residues within 4Å:- Chain A: N.12, T.14, L.53, L.55, R.64, R.196
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain A: N.98, Q.120, T.143, R.146
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain A: N.346
- Chain B: L.432, Y.464, N.468
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: I.1104, N.1105
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain B: Q.15, N.48, P.606
Ligand excluded by PLIPNAG.26: 7 residues within 4Å:- Chain B: N.108, S.109, T.110, H.111, V.113, H.136, V.153
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: N.307, K.555, L.557
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain A: Q.807
- Chain B: N.591, Q.619
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: H.630, V.631, N.632
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: N.680, N.681, I.1101, G.1102
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain A: Q.866
- Chain B: A.677, E.1043, N.1045
Ligand excluded by PLIPNAG.32: 6 residues within 4Å:- Chain B: R.1044, N.1069, G.1070, T.1071, S.1072, F.1074
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain B: R.146, N.147
- Chain C: Y.327, A.328, I.444
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain B: D.256, E.257, N.258
- Chain C: R.533
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: N.319, S.347, L.417
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain B: N.12, T.14, R.51, L.53, R.64
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain B: N.98, T.99, Q.120, R.146
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain B: N.346
- Chain C: L.432, Y.464, N.468
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain B: N.1105
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain C: Q.15, N.48, P.606, R.609
Ligand excluded by PLIPNAG.41: 6 residues within 4Å:- Chain C: N.108, S.109, T.110, H.111, V.113, V.153
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: N.307, P.554, K.555
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain B: Q.807
- Chain C: N.591, Q.619
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain C: H.630, N.632
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain C: N.680, N.681, I.1101, G.1102
Ligand excluded by PLIPNAG.46: 5 residues within 4Å:- Chain B: Q.866
- Chain C: A.677, E.1043, R.1044, N.1045
Ligand excluded by PLIPNAG.47: 6 residues within 4Å:- Chain C: R.1044, N.1069, G.1070, T.1071, S.1072, F.1074
Ligand excluded by PLIPNAG.48: 5 residues within 4Å:- Chain A: Y.327, A.328, I.444
- Chain C: R.146, N.147
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain A: R.533
- Chain C: D.256, E.257, N.258
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain C: N.319, S.347, T.348, L.417
Ligand excluded by PLIPNAG.51: 5 residues within 4Å:- Chain C: N.12, T.14, R.51, L.53, R.64
Ligand excluded by PLIPNAG.52: 5 residues within 4Å:- Chain C: D.97, N.98, T.99, Q.120, R.146
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain A: L.432, Y.464, N.468
- Chain C: N.346
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain C: I.1104, N.1105
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hueting, D. et al., Design, structure and plasma binding of ancestral beta-CoV scaffold antigens. Nat Commun (2023)
- Release Date
- 2023-08-16
- Peptides
- Spike glycoprotein,Fibritin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
B
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hueting, D. et al., Design, structure and plasma binding of ancestral beta-CoV scaffold antigens. Nat Commun (2023)
- Release Date
- 2023-08-16
- Peptides
- Spike glycoprotein,Fibritin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
B